日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma

利妥昔单抗联合CHOP方案每21天或14天治疗原发性纵隔大B细胞淋巴瘤的真实临床经验

Karakatsanis, Stamatis J; Bouzani, Maria; Symeonidis, Argyris; Angelopoulou, Maria K; Papageorgiou, Sotirios G; Michail, Michail; Gainaru, Gabriella; Kourti, Georgia; Sachanas, Sotirios; Kalpadakis, Christina; Katodritou, Eirini; Leonidopoulou, Theoni; Kotsianidis, Ioannis; Hatzimichael, Eleftheria; Kotsopoulou, Maria; Dimou, Maria; Variamis, Eleni; Boutsis, Dimitrios; Kanellias, Nick; Dimopoulou, Maria N; Michali, Evridiki; Karianakis, George; Tsirkinidis, Pantelis; Vadikolia, Chryssa; Poziopoulos, Christos; Pigaditou, Anna; Vrakidou, Effimia; Economopoulos, Theophanis; Kyriazopoulou, Lydia; Siakantaris, Marina P; Kyrtsonis, Marie-Christine; Anargyrou, Konstantinos; Papaioannou, Maria; Hatjiharissi, Evdoxia; Vervessou, Elissavet; Tsirogianni, Maria; Palassopoulou, Maria; Stefanoudaki, Ekaterini; Zikos, Panayiotis; Tsirigotis, Panayiotis; Tsourouflis, Gerassimos; Assimakopoulou, Theodora; Verrou, Evgenia; Papadaki, Helen; Lampropoulou, Polixeni; Dimopoulos, Meletios-Athanasios; Pappa, Vassiliki; Konstantopoulos, Kostas; Karmiris, Themis; Roussou, Paraskevi; Panayiotidis, Panayiotis; Pangalis, Gerassimos A; Vassilakopoulos, Theodoros P

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP

识别接受 R-CHOP 方案治疗的原发性纵隔大 B 细胞淋巴瘤患者的极低风险亚组

Vassilakopoulos, Theodoros P; Michail, Michail; Papageorgiou, Sotirios; Kourti, Georgia; Angelopoulou, Maria K; Panitsas, Fotios; Sachanas, Sotirios; Kalpadakis, Christina; Katodritou, Eirini; Leonidopoulou, Theoni; Kotsianidis, Ioannis; Hatzimichael, Eleftheria; Kotsopoulou, Maria; Dimou, Maria; Variamis, Eleni; Boutsis, Dimitrios; Terpos, Evangelos; Dimopoulou, Maria N; Karakatsanis, Stamatios; Michalis, Eurydiki; Karianakis, George; Tsirkinidis, Pantelis; Vadikolia, Chryssa; Poziopoulos, Christos; Pigaditou, Anna; Vrakidou, Effimia; Economopoulos, Theophanis; Kyriazopoulou, Lydia; Siakantaris, Marina P; Kyrtsonis, Marie-Christine; Symeonidis, Argyris; Anargyrou, Konstantinos; Papaioannou, Maria; Hatjiharissi, Evdoxia; Vervessou, Elissavet; Tsirogianni, Maria; Palassopoulou, Maria; Gainaru, Gabriella; Stefanoudaki, Ekaterini; Zikos, Panayiotis; Tsirigotis, Panayiotis; Tsourouflis, Gerasimos; Assimakopoulou, Theodora; Konstantinidou, Pavlina; A Papadaki, Helen; Megalakaki, Katerina; Dimopoulos, Meletios-Athanasios; Pappa, Vassiliki; Karmiris, Themis; Roussou, Paraskevi; Panayiotidis, Panayiotis; Konstantopoulos, Kostas; Pangalis, Gerassimos A

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

有症状的华氏巨球蛋白血症患者的竞争风险生存分析:疾病无关死亡率和基于利妥昔单抗的一线治疗的影响

Kastritis, Efstathios; Kyrtsonis, Marie-Christine; Morel, Pierre; Gavriatopoulou, Maria; Hatjiharissi, Evdoxia; Symeonidis, Argirios S; Vassou, Amalia; Repousis, Panagiotis; Delimpasi, Sossana; Sioni, Anastasia; Michalis, Evrydiki; Michael, Michail; Vervessou, Elina; Voulgarelis, Michael; Tsatalas, Costantinos; Terpos, Evangelos; Dimopoulos, Meletios A